Mr Eng joined the SATS Board on 15 April 2023 as a Non-Executive and Independent Director and subsequently, was re-designated as a Non-Executive and Non-Independent Director on 1 September 2024 following his executive appointments in Temasek International Pte. Ltd. (“Temasek International”). He is currently a member of the RHRC and the NC. He was last re-elected as a Director on 25 July 2025.
Mr Eng has over 30 years of global business and operating experience in the healthcare and maritime industries, including a proven track record in private equity investments. His present principal commitments include his roles as the joint head of the portfolio development group at Temasek Singapore Pte Ltd and head of the operating group at Temasek International. In these roles with Temasek, Mr Eng also sits on some of its portfolio companies’ boards and investment committees. He also serves as a non-executive and non-independent director at Seatrium Limited, a company listed on the SGX-ST.
Mr Eng has held various prominent roles in the past, including co-founder of TE Asia Healthcare Partners, group chief executive officer of TE Healthcare Advisory Pte. Ltd., and group chief operating officer of Fortis Healthcare International. He also worked as a senior advisor for TPG Capital, where he was involved in directorships and leadership roles across portfolio companies. Before joining the healthcare industry, Mr Eng spent 18 years with Neptune Orient Lines in various leadership roles.
Mr Eng holds a Bachelor of Accountancy with Honours from Nanyang Technological University and a Master of Business Administration from Harvard University.
